Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.1093/eurheartj/ehs092 | European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) |
| https://doi.org/10.1093/eurheartj/ehw106 | 2016 European Guidelines on cardiovascular disease prevention in clinical practice |
| https://doi.org/10.1093/eurheartj/ehab484 | 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice |
| https://doi.org/10.1093/eurheartj/ehm316 | European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts) |
| https://doi.org/10.1097/01.hjr.0000277983.23934.c9 | Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) |
| https://doi.org/10.1177/2047487316653709 | 2016 European Guidelines on cardiovascular disease prevention in clinical practice |
| https://doi.org/10.1093/eurjpc/zwab154 | 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice |
| https://doi.org/10.1016/j.atherosclerosis.2016.05.037 | 2016 European Guidelines on cardiovascular disease prevention in clinical practice |
| https://doi.org/10.1007/s12529-012-9242-5 | European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) |
| https://doi.org/10.1161/cir.0b013e318267e99f | Our Time: A Call to Save Preventable Death From Cardiovascular Disease (Heart Disease and Stroke) |
| https://doi.org/10.1097/00149831-200312001-00001 | European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts) |
| https://doi.org/10.1038/s41572-020-0188-7 | Inherited cardiac arrhythmias |
| https://doi.org/10.1016/j.rec.2016.09.009 | 2016 European Guidelines on cardiovascular disease prevention in clinical practice |
| https://doi.org/10.1177/2047487312441726 | Population-level changes to promote cardiovascular health |
| https://doi.org/10.1714/2729.27821 | Linee guida europee 2016 sulla prevenzione delle malattie cardiovascolari nella pratica clinica. Sesta Task Force congiunta della Società Europea di Cardiologia e di altre Società sulla Prevenzione delle Malattie Cardiovascolari nella Pratica Clinica (costituita da rappresentanti di 10 società e da esperti invitati). Redatte con il contributo straordinario dell’Associazione Europea per la Prevenzione e Riabilitazione Cardiovascolare (EACPR) |
| https://doi.org/10.1177/23971983211053246 | Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition |
| https://doi.org/10.1093/eurheartj/ehs313 | Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke) |
| https://doi.org/10.1016/s2589-7500(22)00151-0 | CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical research |
| https://doi.org/10.3390/healthcare10091629 | European Health Data Space—An Opportunity Now to Grasp the Future of Data-Driven Healthcare |
| https://doi.org/10.5334/gh.1132 | The Impact of Alcohol Consumption on Cardiovascular Health: Myths and Measures |
| https://doi.org/10.1136/bmj-2021-069048 | CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research |
| https://doi.org/10.5334/gh.935 | World Heart Federation Policy Brief: Front-Of-Pack Labelling |
| https://doi.org/10.1016/j.gheart.2012.08.002 | Our Time: A Call to Save Preventable Death From Cardiovascular Disease (Heart Disease and Stroke) |
| https://doi.org/10.1016/j.gheart.2014.09.003 | Sustainable Development Goals and the Future of Cardiovascular Health: A Statement From the Global Cardiovascular Disease Taskforce |
| https://doi.org/10.1093/eurheartj/ehac426 | CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research |
| https://doi.org/10.1038/s41598-021-84920-4 | Proof-of-concept trial results of the HeartMan mobile personal health system for self-management in congestive heart failure |
| https://doi.org/10.1186/1471-2458-14-456 | Economics of chronic diseases protocol: cost-effectiveness modelling and the future burden of non-communicable disease in Europe |
| https://doi.org/10.3205/hta000136 | The time is now: Achieving FH paediatric screening across Europe – The Prague Declaration |
| https://doi.org/10.1016/j.repce.2013.07.001 | European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) |
| https://doi.org/10.2196/36797 | Patients’ and Publics’ Preferences for Data-Intensive Health Research Governance: Survey Study |
| https://doi.org/10.5334/gh.1308 | More People, More Active, More Often for Heart Health – Taking Action on Physical Activity |
| https://doi.org/10.3389/fmed.2024.1365501 | Artificial intelligence based data curation: enabling a patient-centric European health data space |
| https://doi.org/10.1186/s12885-022-09184-1 | Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission – results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial |
| https://doi.org/10.1080/20479700.2024.2417639 | Evaluation of referral pathways for coronary artery bypass surgery patients; comparison on clinical outcomes, quality of life and process parameters |
| https://doi.org/10.1093/ehjacc/zuaf057 | Clinical management of acute myocarditis in daily practice: an expert practical view |
| https://doi.org/10.1161/jaha.114.000504 | Sustainable Development Goals and the Future of Cardiovascular Health: A Statement From the Global Cardiovascular Disease Taskforce |
| https://doi.org/10.1016/j.jacc.2014.08.018 | Sustainable Development Goals and the Future of Cardiovascular Health |
| https://doi.org/10.1016/j.puhe.2012.12.025 | Measuring the food and built environments in urban centres: Reliability and validity of the EURO-PREVOB Community Questionnaire |
| https://doi.org/10.5334/gh.935 | World Heart Federation Policy Brief: Front-Of-Pack Labelling: Unhealthy Changes in the Global Food System. |
| https://doi.org/10.1097/01.hjr.0000275426.85303.8c | The European Heart Health Charter: towards a healthier Europe |
| https://doi.org/10.1016/j.gheart.2013.08.013 | Moving From Political Declaration to Action on Reducing the Global Burden of Cardiovascular Diseases: A Statement From the Global Cardiovascular Disease Taskforce |
| https://doi.org/10.1016/j.repc.2013.06.001 | Recomendações Europeias para a prevenção da doença cardiovascular na prática clínica (versão de 2012) |
| https://doi.org/10.1016/j.rec.2023.03.001 | Univentricular hearts not undergoing Fontan: the type of palliation matters |
| https://doi.org/10.1093/ejcts/ezaf310 | Biogenic Polymers for Congenital Cardiac Surgery: In Vitro Durability Testing |
| https://doi.org/10.1109/dph66411.2025.11198049 | Integrating Participatory Research and Literature Review to Identify Social and Ethical Requirements for Responsible AI in Heart Failure Treatment |
| Europejskie wytyczne dotyczace zapobiegania chorobom serca i naczyń w praktyce klinicznej na 2012 rok | |
| https://doi.org/10.1016/j.cvdpc.2008.02.002 | World Heart Federation regional reports |
| https://doi.org/10.20996/1819-6446-2008-4-4-90-107 | EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE (ENDING). FOURTH JOINT TASK FORCE OF THE EUROPEAN SOCIETY OF CARDIOLOGY AND OTHER SOCIETIES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE |
| https://doi.org/10.5334/gh.935 | Healthy Choices for Healthy Hearts: How Front-of-Pack Food Labeling Can Help Reverse the Global Obesity Epidemic |
| https://doi.org/10.1097/01.hjr.0000087913.96265.e2 | European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). |
| https://doi.org/10.1714/1264.13965 | Cambiamenti a livello di popolazione per promuovere la salute cardiovascolare |
| Linee guida Europee sulla prevenzione delle malattie cardiovascolari nella pratica clinica: Riassunto esecutivo | |
| https://doi.org/10.1007/s12471-023-01789-w | Importance of exercise stress testing in evaluation of unexplained cardiac arrest survivor |
| https://doi.org/10.3324/haematol.2025.287510 | Bortezomib-melphalan-prednisone versus lenalidomide-dexamethasone in elderly patients with multiple myeloma: the Real MM phase IV trial |
| https://doi.org/10.55295/psl.13.2025.10 | Transformative Educational Strategies wi th Artificial Intelligence: Redefining Access to Information and the Evolving Role of Educators |
| https://doi.org/10.3324/haematol.2025.288675 | The added value of Bayesian interim analysis in randomized phase II and phase III clinical trials in hemato-oncology |
| https://doi.org/10.3324/haematol.2025.s1.12853 | B01 | ANALYSIS OF SUSTAINED MINIMAL RESIDUAL DISEASE NEGATIVITY IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE WITH OR WITHOUT ISATUXIMAB (PHASE III ISKIA TRIAL) |
| https://doi.org/10.5281/zenodo.18375054 | Integrating participatory research and literature review to identify social and ethical requirements for responsible AI in heart failure treatment |
| https://doi.org/10.5281/zenodo.18375055 | Integrating participatory research and literature review to identify social and ethical requirements for responsible AI in heart failure treatment |
| https://doi.org/10.5281/zenodo.18415472 | Short Guide for Screening Individuals at Increased Risk of Developing CVDs and T2D |
| https://doi.org/10.5281/zenodo.18415471 | Short Guide for Screening Individuals at Increased Risk of Developing CVDs and T2D |
| https://doi.org/10.1080/13696998.2026.2624972 | Indirect treatment comparison of DVRd plus DR maintenance (PERSEUS study) versus DVTd or VTd with or without lenalidomide maintenance in transplant-eligible patients with previously untreated multiple myeloma |
| https://doi.org/10.3389/fcvm.2026.1665734 | Cardiovascular phenotyping of children and adolescents with post-COVID syndrome (PCS) at initial diagnosis - a prospective observational single-center study |
| https://doi.org/10.1007/978-1-84628-502-8_42 | National Heart Foundations, European Heart Network |